The senior vice president of Research & Early Development at Notch Therapeutics discussed the company’s approach to overcoming the drawbacks of autologous cell therapies.
Chris Bond, PhD
Advertisement
Articles by Chris Bond, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
FasTCAR Manufactured BCMAxCD19 CAR T-cell Therapy Shows Promise for Multiple Myeloma
2
Crawford Strunk, MD, on the Importance of Palliative Care in Sickle Cell Disease
3
The Importance of Palliative Care in Sickle Cell Disease
4
FDA Approves BMS’s Liso-Cel for R/R Marginal Zone Lymphoma
5
